SCHEMBL2233701

SCHEMBL2233701

Cc1ccc(C2=Cc3c(ccc(C)c3-c3ccc4ccccc4c3)C2[Si](C)(C)C2C(c3ccc(C)o3)=Cc3c2ccc(C)c3-c2ccc3ccccc3c2)o1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
CYP1A2 P05177 2/20 0.34
HSD17B10 Q99714 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34
PTGS2 P35354 2/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
MAPT P10636 2/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2234262 0.86 PTGS1 (0.40) SMN1; SMN2ALDH1A1HPGDHSD17B10PTGS2
SCHEMBL2235899 0.86 PTGS1 (0.42) SMN1; SMN2ALDH1A1HPGDHSD17B10PTGS2
SCHEMBL22499689 0.86 ALDH1A1 (0.34) IKBKBSMN1; SMN2ALDH1A1HPGDCYP1A2
SCHEMBL2234850 0.83 KDM4E (0.31) ALDH1A1HPGDMEN1KMT2AMAPT
SCHEMBL2234973 0.82 GSK3B (0.37) SMN1; SMN2ALDH1A1HPGDHSD17B10TSHR
SCHEMBL15712970 0.82 PTGS1 (0.37) SMN1; SMN2ALDH1A1HPGDHSD17B10PTGS2
SCHEMBL2384976 0.82 KIF11 (0.33) SMN1; SMN2ALDH1A1HPGDPTGS2MEN1
SCHEMBL2235889 0.81 MAPT (0.40) SMN1; SMN2ALDH1A1HPGDCYP1A2HSD17B10
SCHEMBL2237161 0.81 DHFR (0.36) ALDH1A1ADORA2AADORA1KDM4EALOX15
SCHEMBL2235921 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461365-B2 Metallocene complex and polymerization method of olefin JAPAN POLYPROPYLENE CORPORATION (JP) 2013-06-11 US disclosed
US-20110230622-A1 METALLOCENE COMPLEX AND POLYMERIZATION METHOD OF OLEFIN JAPAN POLYPROPYLENE CORPORATION (JP) 2011-09-22 US disclosed
EP-2360163-A1 METALLOCENE COMPLEX AND METHOD FOR POLYMERIZING OLEFIN Japan Polypropylene Corporation (JP) 2011-08-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230622-A1 METALLOCENE COMPLEX AND POLYMERIZATION METHOD OF OLEFIN ALOX12, ALOX15, ALOX15B IKBKB 3916/4885SMN1; SMN2 2008/4885ALDH1A1 477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.